Bibliometric analysis of research on sarcopenic obesity: a review of scientific literature.
adiposity
obesity
sarcopenia
sarcopenic obesity
Journal
Obesity reviews : an official journal of the International Association for the Study of Obesity
ISSN: 1467-789X
Titre abrégé: Obes Rev
Pays: England
ID NLM: 100897395
Informations de publication
Date de publication:
28 May 2024
28 May 2024
Historique:
revised:
04
05
2024
received:
29
07
2023
accepted:
06
05
2024
medline:
29
5
2024
pubmed:
29
5
2024
entrez:
29
5
2024
Statut:
aheadofprint
Résumé
Considering the current prevalence in obesity and sarcopenia globally, this study aimed to summarize the development of sarcopenic obesity research to establish the topic's past, present, and future research direction using a bibliometric analysis. A comprehensive search for publications on sarcopenia and obesity was conducted in the Web of Science (WoS) database until the 31st of December 2023. We performed a detailed descriptive analysis, considering metrics like sources, authors, and documents, along with analyzing conceptual and social structures to map sarcopenic obesity research. Between 1993 and 2023, there were 4978 publications on sarcopenic obesity, representing 22.6% of the whole sarcopenia research (22070). Most published articles were originals (74.6%), and one of the highest increments in the fields was seen after 2010. The most significant contribution in this research area falls under the categories of Nutrition & Dietetics, Gerontology, and Geriatrics & Gerontology. Among regions, scientific production was located in 93 different countries. The United States, China, and South Korea had the highest contributions. The most relevant keywords were sarcopenia, obesity, and body composition. Research on sarcopenic obesity primarily focuses on epidemiology and identifying risk factors and outcome predictors. Yet, there is a shortage of research addressing prevention, early detection, and treatments to enhance the health of individuals with sarcopenia.
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
e13784Informations de copyright
© 2024 The Author(s). Obesity Reviews published by John Wiley & Sons Ltd on behalf of World Obesity Federation.
Références
WHO. Obesity and overweight. 2021. https://www.who.int/news-room/fact-sheets/detail/obesity-and-overweight
Obesity W. One billion people globally estimated to be living with obesity by 2030. https://www.worldobesity.org/news/one-billion-people-globally-estimated-to-be-living-with-obesity-by-2030
Kim SA, Lim K, Lee JK, Kang D, Shin S. Metabolically healthy obesity and the risk of all‐cause and cardiovascular disease mortality in a Korean population: a prospective cohort study. BMJ Open. 2021;11(9):e049063. doi:10.1136/bmjopen‐2021‐049063
Soteriades ES, Hauser R, Kawachi I, Liarokapis D, Christiani DC, Kales SN. Obesity and cardiovascular disease risk factors in firefighters: a prospective cohort study. Obes Res. 2005;13(10):1756‐1763. doi:10.1038/oby.2005.214
Inan‐Eroglu E, Huang BH, Sarich P, Nassar N, Stamatakis E. Joint association of alcohol consumption and adiposity with alcohol‐ and obesity‐related cancer in a population sample of 399,575 UK adults. Br J Nutr. 2023;130(3):503‐512. doi:10.1017/S0007114522003464
Parra‐Soto S, Petermann‐Rocha F, Boonpor J, et al. Combined association of general and central obesity with incidence and mortality of cancers in 22 sites. Am J Clin Nutr. 2021;113(2):401‐409. doi:10.1093/ajcn/nqaa335
Marty E, Liu Y, Samuel A, Or O, Lane J. A review of sarcopenia: enhancing awareness of an increasingly prevalent disease. Bone. 2017;105:276‐286. doi:10.1016/j.bone.2017.09.008
Dennison EM, Sayer AA, Cooper C. Epidemiology of sarcopenia and insight into possible therapeutic targets. Nat Rev Rheumatol. 2017;13(6):340‐347. doi:10.1038/nrrheum.2017.60
Cruz‐Jentoft AJ, Bahat G, Bauer J, et al. Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing. 2019;48(1):16‐31. doi:10.1093/ageing/afy169
WHO. Musculoskeletal conditions. World Health Organization. 2018. Available at: http://www.who.int/mediacentre/factsheets/musculoskeletal/en/
Rosenberg IH. Summary comments. Am J Clin Nutr. 1989;50(5):1231‐1233. doi:10.1093/ajcn/50.5.1231
Donini LM, Busetto L, Bischoff SC, et al. Definition and diagnostic criteria for sarcopenic obesity: ESPEN and EASO consensus statement. Obes Facts. 2022;15(3):321‐335. doi:10.1159/000521241
Cruz‐Jentoft AJ, Baeyens JP, Bauer JM, et al. Sarcopenia: European consensus on definition and diagnosis: report of the European Working Group on Sarcopenia in Older People. Age Ageing. 2010;39(4):412‐423. doi:10.1093/ageing/afq034
Fielding RA, Vellas B, Evans WJ, et al. Sarcopenia: an undiagnosed condition in older adults. Current consensus definition: prevalence, etiology, and consequences. International working group on sarcopenia. J am med Dir Assoc. 2011;12(4):249‐256. doi:10.1016/j.jamda.2011.01.003
Studenski SA, Peters KW, Alley DE, et al. The FNIH sarcopenia project: rationale, study description, conference recommendations, and final estimates. J Gerontol a Biol Sci med Sci. 2014;69(5):547‐558. doi:10.1093/gerona/glu010
Chen LK, Liu LK, Woo J, et al. Sarcopenia in Asia: consensus report of the Asian Working Group for Sarcopenia. J am med Dir Assoc. 2014;15(2):95‐101. doi:10.1016/j.jamda.2013.11.025
Cruz‐Jentoft AJ, Landi F, Schneider SM, et al. Prevalence of and interventions for sarcopenia in ageing adults: a systematic review. report of the international sarcopenia initiative (EWGSOP and IWGS). Age Ageing. 2014;43(6):748‐759. doi:10.1093/ageing/afu115
Hwang J, Park S. Korean nationwide exploration of sarcopenia prevalence and risk factors in late middle‐aged women. Healthcare (Basel). 2024;12(3):362. doi:10.3390/healthcare12030362
Liu P, Hao Q, Hai S, Wang H, Cao L, Dong B. Sarcopenia as a predictor of all‐cause mortality among community‐dwelling older people: a systematic review and meta‐analysis. Maturitas. 2017;103:16‐22. doi:10.1016/j.maturitas.2017.04.007
Li X, Ploner A, Karlsson IK, et al. The frailty index is a predictor of cause‐specific mortality independent of familial effects from midlife onwards: a large cohort study. BMC med. 2019;17(1):94. doi:10.1186/s12916‐019‐1331‐8
Hanlon P, Nicholl BI, Jani BD, Lee D, McQueenie R, Mair FS. Frailty and pre‐frailty in middle‐aged and older adults and its association with multimorbidity and mortality: a prospective analysis of 493 737 UK biobank participants. Lancet Public Health. 2018;3(7):e323‐e332. doi:10.1016/S2468‐2667(18)30091‐4
Petermann‐Rocha F, Balntzi V, Gray SR, et al. Global prevalence of sarcopenia and severe sarcopenia: a systematic review and meta‐analysis. J Cachexia Sarcopenia Muscle. 2022;13(1):86‐99. doi:10.1002/jcsm.12783
WHO. Obesity rising in Africa, WHO analysis finds. 2022. https://www.afro.who.int/news/obesity-rising-africa-who-analysis-finds#:~:text=Brazzaville%20%E2%80%93%20One%20in%20five%20adults,Organization%20(WHO)%20analysis%20shows
Kirk B, Cawthon PM, Arai H, et al. Global leadership initiative in sarcopenia (GLIS) group. The conceptual definition of sarcopenia: Delphi consensus from the global leadership initiative in sarcopenia (GLIS). Age Ageing. 2024;53:afae052.
Barazzoni R, Bischoff SC, Boirie Y, et al. Sarcopenic obesity: time to meet the challenge. Clin Nutr (Edinburgh, Scotland). 2018;37(6):1787‐1793. doi:10.1016/j.clnu.2018.04.018
Agarwal A, Durairajanayagam D, Tatagari S, et al. Bibliometrics: tracking research impact by selecting the appropriate metrics. Asian J Androl. 2016;18(2):296‐309. doi:10.4103/1008‐682X.171582
Falagas ME, Pitsouni EI, Malietzis GA, Pappas G. Comparison of PubMed, Scopus, Web of Science, and Google Scholar: strengths and weaknesses. FASEB j. 2008;22(2):338‐342. doi:10.1096/fj.07‐9492LSF